《公司業績》香格里拉(亞洲)(00069.HK)全年虧轉盈賺1.84億美元 恢復派末期息15港仙
香格里拉(亞洲)(00069.HK)公布截至去年12月底止全年業績,營業額21.42億美元(下同),按年升46.5%。虧轉盈賺1.84億元,上年同期蝕1.58億元;每股盈利5.17美仙。派末期息15港仙,上年同期不派息。
就香港而言,去年度入住率為70%,按年升32個百分點。去年度,每房收入為199美元,按年增加165%。受中國大陸商務及休閒旅遊需求復甦的推動,集團香港酒店的入住率及每房收入均出現強勁復甦。去年度,香港酒店物業的總收入增加94.2%至3.04億美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.